Rivaroxaban 15mg Tablets

Rivaroxaban 15mg is an oral anticoagulant used during the initial treatment of deep-vein thrombosis or pulmonary embolism. It is also used for stroke prevention in non-valvular atrial fibrillation when reduced kidney function calls for this strength.
Take every 15mg dose with food. Initial adult DVT or pulmonary-embolism treatment commonly uses twice-daily dosing for 21 days before a planned change; selected atrial-fibrillation regimens use once-daily dosing with the evening meal. Do not confuse the two schedules.
Rivaroxaban directly inhibits activated factor X, or factor Xa. This reduces thrombin generation and the formation of fibrin clots without acting as a platelet inhibitor like aspirin.
Bruising, nosebleeds, gum bleeding and anaemia can occur. Bleeding that will not stop, black stools, blood in urine, vomiting blood, a severe headache after a fall or sudden weakness needs urgent assessment.
Do not use during active significant bleeding or liver disease that impairs clotting. Kidney function affects the choice of dose and regimen. Strong CYP3A4/P-glycoprotein inhibitors or inducers can alter rivaroxaban levels. Tell the surgical or dental team before a procedure, particularly a spinal or epidural procedure. NSAIDs, antiplatelets and other anticoagulants increase bleeding risk.
Reduces the risk of a harmful clot forming, growing or recurring in the circulation.
Routine INR testing is not used to adjust rivaroxaban. Kidney function, haemoglobin, bleeding symptoms and interactions still need periodic assessment.
No. It reduces further clot formation while the body's own processes gradually break down the existing clot.
Ibuprofen, naproxen and other NSAIDs can increase bleeding when combined with rivaroxaban. Do not add them for pain without first arranging a suitable pain-relief option.
The dentist needs to plan for bleeding and the timing of treatment. Do not miss rivaroxaban doses on your own before dental work.
Factor Xa: an activated clotting protein involved in thrombin generation. Anticoagulant: a medicine reducing blood-clot formation. Venous thromboembolism: a clot in a deep vein or lung circulation. Non-valvular atrial fibrillation: an irregular atrial rhythm without certain valve conditions. Haemostasis: the process of stopping bleeding.; AR: Rivaroxaban 15mg أقراص; FR: Rivaroxaban 15mg comprimés; PT: Rivaroxaban 15mg comprimidos; ES: Rivaroxaban 15mg comprimidos; RU: Rivaroxaban 15mg таблетки; ID: Rivaroxaban 15mg tablet; VI: Rivaroxaban 15mg viên nén; MS: Rivaroxaban 15mg tablet; TL: Rivaroxaban 15mg tableta; ZH-SG: Rivaroxaban 15mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Rivaroxaban 15mg Tablets under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Rivaroxaban 15mg Tablets